AZN
AstraZeneca Hits Stride in Q2 2026 with Strong Growth Momentum and Pipeline Deliveries
AstraZeneca, one of the world's leading biopharmaceutical companies, has kicked off its second quarter (Q2) presentation conference call for investors and analysts. The company reported strong growth momentum and continued pipeline delivery in the first half of 2026. Total revenue grew by 6% during this period, driven by